Simulation Systems in North Carolina

Laboratory Corporation of America Holdings (Labcorp) is a global leader in laboratory services headquartered in Burlington, North Carolina. Operating in approximately 100 countries with over 70,000 employees, Labcorp performs more than 700 million tests annually and generates $13.01 billion in revenue. The company provides comprehensive clinical diagnostics, drug development support, and specialized testing including oncology, rare diseases, and genomic sequencing. Labcorp's integrated platform connects diagnostics to biopharma development, supporting healthcare providers, researchers, and investigators. Key offerings include AI-powered diagnostic assistance tools, real-world data platforms for drug development, genetic testing services (including Invitae), nonclinical research, central laboratory services, and clinical trial support. The company serves patients, healthcare providers, health systems, managed care organizations, and biopharmaceutical companies. Over 75% of new drugs approved by the FDA have been supported by Labcorp's services.

Blur Development Group is a full-service medical device design, development, and contract manufacturing firm founded in 2015. Headquartered in Cary, NC, the company provides end-to-end services from concept through commercialization, including mechanical, electrical, and software engineering; industrial and human-factors design; prototyping; verification and validation testing; FDA regulatory strategy and submissions; and electromechanical contract manufacturing. The firm operates an ISO 13485-certified manufacturing facility established in 2020 and maintains Part 820 (FDA Quality System Regulation) compliance. Services span embedded systems and firmware development, user interface design, microfluidics, robotics design, optical and optomechanical engineering, wearables, biosensors, and home healthcare applications. Blur works with early-stage startups and established medical device companies, offering transparent pricing, supply chain management, component procurement, and inventory management. The company employs over 50 personnel across two facilities and has successfully developed dozens of medical devices for clients seeking external product development expertise. Blur's approach emphasizes cross-discipline collaboration, rapid innovation cycles, and integrated quality and manufacturing engineering to accelerate time-to-market while maintaining regulatory compliance.

Veranex is the industry's first fully integrated Innovation CRO (Contract Research Organization), headquartered in Raleigh, North Carolina. Founded in 2021, the company unites product design, engineering, manufacturing, preclinical research, clinical research, regulatory affairs, quality management, and market-access expertise under one roof to accelerate medical device and in vitro diagnostic (IVD) development from concept to commercialization. With over 800 cross-disciplinary specialists across 15 international hubs (including London and Bangalore), Veranex serves 700+ global clients and has accelerated 1,000+ programs. The company specializes in cardiovascular, neurovascular, ophthalmology, and diagnostic device innovation, offering integrated services including GLP/non-GLP preclinical studies, optimized clinical trial design and execution, FDA and EU-MDR regulatory strategy, ISO 13485 quality management systems, contract manufacturing with scalable volumes, and commercialization support. Veranex emphasizes patient-centric innovation, cross-disciplinary collaboration, and accountability to eliminate traditional CRO fragmentation and reduce development timelines and costs.